产品介绍：
产品说明
应用
Redi-Dri™ is an innovative packaging product line that helps eliminate clumping material by adding extra packaging process steps without any chemical additives, anti-clumping agents, or hydrophobic compounds. Redi-Dri™ offers a more convenient and safer way to handle the products.
生化/生理作用
MAO 抑制剂;抑制血小板聚集。
法律信息
Redi-Dri is a trademark of sigma-aldrich Co. LLC
基本信息
| 线性分子式 | NH2OH · HCl |
| 分子量 | 69.49 |
| Beilstein | 3539763 |
| MDL编号 | MFCD00051089 |
产品性质
| 等级 | ACS reagent |
| 蒸汽压 | 0.001 hPa ( 50 ℃) |
| 产品线 | Redi-Dri™ |
| 测定 | 98.0% |
| 形式 | powder |
| pH值(酸碱度) | 2.5-3.5 (20 ℃, 50 g/L) |
| mp | 155-157 ℃ (dec.) (lit.) |
| 密度 | 1.67 g/mL at 25 ℃ (lit.) |
| 痕量阴离子 | sulfur compounds (as SO42-): ≤0.005% |
| 痕量阳离子 | Fe: ≤ 5 ppm NH4+:, passes test heavy metals: ≤ 5 ppm |
| SMILES string | Cl.NO |
| InChI | 1S/ClH.H3NO/c;1-2/h1H;2H,1H2 |
| InChI key | WTDHULULXKLSOZ-UHFFFAOYSA-N |
安全信息
| 象形图 |     |
| 警示用语： | Warning |
| 危险声明 | H290 - H302 + H312 - H315 - H317 - H319 - H351 - H373 - H400 |
| 预防措施声明 | P273 - P280 - P301 + P312 - P302 + P352 + P312 - P305 + P351 + P338 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Eye Irrit. 2 - Met. Corr. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2 Oral |
| 靶器官 | spleen |
| 储存分类代码 | 4.1A - Other explosive hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
